Claris Lifesciences Limited

BSE: 533288
₹396.55
▼ -0.25 (-0.06%)
March 14, 2018 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
56/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
11.5
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

2 of 2 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

2 of 4 met
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.1%
Low 395.0000 · High 396.9000
1W return
0.6%
Low 392.1000 · High 397.2000
1M return
1.7%
Low 356.0000 · High 397.2000
52W return
23.8%
Low 308.0000 · High 425.7000
Lifetime High ₹396.8000 (March 13, 2018)
Lifetime Low ₹99.7000 (Dec. 19, 2011)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
395.9
10D
394.7
20D
391.3
50D
380.9
100D
371.6
200D
361.7

Delivery and volume

Day avg. delivery
98.1%
Week avg. delivery
95.2%
Month avg. delivery
90.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

396.15
Pivot
First resistance397.30
Second resistance398.05
Third resistance399.20
First support395.40
Second support394.25
Third support393.50
Day RSI69.1
Day MFI65.6
Day MACD5.09
Day MACD signal5.64

Beta

1M0.06
3M-0.04
1Y0.14
3Y1.06

Price change analysis

↑ 1.7%
Over 1 Month
LowHigh
356.00397.20
↑ 13.0%
Over 3 Months
LowHigh
344.95397.20
↑ 5.8%
Over 6 Months
LowHigh
311.60425.70
↑ 23.8%
Over 1 Year
LowHigh
308.00425.70
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Dec 2017
  • Promoter50.13%
  • Mutual funds1.93%
  • FII/FPI26.02%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 50.13% in Dec 2017 qtr

Historical fii holding

FII/FPI holdings increased from 25.62% to 26.02% in Dec 2017 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 1.93% in Dec 2017 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
8 Feb 2017 COPTHALL MAURITIUS INVESTMENT LIMITED Block Sell 719,433 313.0000 BSE
8 Feb 2017 ASHOKA PTE LIMITED Block Buy 719,433 313.0000 BSE
8 Feb 2017 COPTHALL MAURITIUS INVESTMENT LIMITED Bulk Sell 719,433 313.0000 BSE
8 Feb 2017 ASHOKA PTE LIMITED Bulk Buy 719,433 313.0000 BSE
24 Oct 2016 EVEREST FINANCE AND INVESTMENT COMPANY Bulk Buy 289,789 270.0000 BSE
24 Oct 2016 ABELLON ENERGY LIMITED Bulk Sell 1,175,050 270.8800 BSE
27 Jul 2016 MORGAN STANLEY ASIA SINGAPORE PTE Bulk Buy 783,552 210.0000 BSE
27 Jul 2016 EAST BRIDGE CAPITAL MASTER FUND LIMITED Bulk Buy 2,420,000 210.0000 BSE
27 Jul 2016 ABELLON ENERGY LIMITED Bulk Sell 4,600,000 211.6600 BSE
1 Oct 2015 RELIANCE MUTUAL FUND Bulk Buy 625,000 201.0000 BSE

All bulk and block deals →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Claris Lifesciences Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.